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We review the results of our work on the iodine interaction with thioamides, selenoamides, and amides. Complexes with
(i) “spoke” or “extended spoke” structures, D · I2 and D · I2 · I2, respectively, (D is the ligand donor) (ii) iodonium salts
of {[D2 −I]
+[In]
−} (n = 3, 7) and {[D2 −I]
+[FeCl4]
−} formulae and (iii) disulﬁdes of the categories (a) [D − D], (b)
{[D −DH]
+[I3]
−} have been isolated and characterized. A compound of formula {[D2 −I]
+[I3]
−[D · I2]} containing both types
of complexes (i) and (ii) was also isolated. The interaction of diiodine with selenium analogs of the antithyroid drug 6-n-propyl-2-
thiouracil (PTU), of formulae RSeU (6-alkyl-2-Selenouracil) results in the formation of complexes with formulae [(RSeU)I2]. All
these results are correlated with the mechanism of action of antithyroid drugs. Finally, we review here our work on the diiodine
interaction with the amides (LO).
Copyright © 2006 S. K. Hadjikakou and N. Hadjiliadis. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
INTRODUCTION
The perturbation of the I−I bond when diiodine binds to
heterocycles such as thioamides or selonoamides results to
novel complexes containing iodine [1–13]. Various types
of such complexes have been obtained thus far, including
charge transfer (ct) complexes with the so-called “spoke” or
“extended spoke” structures (DS ·I2 or DS · I2 ·I2)( Di s
the ligand donor) [6], the “T-shape” structures, iodine(I)
coordinated to two thioamides to form “iodonium salts”
([DS−I−DS]+ · (I3)−)[ 6], oxidation products of formulae
(DS−I)+ [6], dications of formulae ([DS−SD]2+(In
−)2), [6]
andmonocationsofformulae([DS−SDH]+(I3)−)[6](DSor
D=S, a thioamide ligand donor).
The interest in studying I2 interaction with thioamides
and selenoamides arises from their application in both bio-
logical chemistry and material sciences. Thus,
(i) thioamides, like 6-n-propyl-thiouracil (PTU), N-
methyl-imidazoline-2-thione (methimazole, MMI),
3-methyl-2-thioxo-4-imidazoline-1-carboxylate (car-
bimazole) (CBZ), are known antithyroid drugs [14]
against hyperthyroidism, while thiazolidine-2-thione
(TZD) and 1,3-bis(hydroxymethyl)-benzimidazoline-
2-thione(BHBZIM)werealsousedassuch,inthepast.
Hyperthyroidism (Grave’s disease) is characterized by
the overproduction of T4a n dT3h o r m o n e s .T h ew a y
that the above and other similar thioamides interact
with I2 is of great importance, in an attempt to ap-
proximate the elucidation of their mechanism of ac-
tion, since I2 is involved in the synthesis of both T4
and T3h o r m o n e s[ 15–17];
(ii) iodine chemistry is recently proving to be of con-
siderable interest because of the discovery of low-
temperature, semi- and superconducting polyiodides,
which quickly led to the deliberate doping of conju-
gated polymers with elemental iodine [13]. The ability
of iodine to catenate leads to the formation of polyio-
dides of various structures [13] reviewed recently by
Boyle et al, Deplano et al, and Svensson et al [10–
13]. The structural variety of polyiodides ranges from
the simple I
−
3 through the linear I2−
4 , the V-shaped I
−
5 ,
three-pronged structures of I
−
7 ,I
−
9 ,I 2−
10 ,a n dI 2−
12 , the Z-
shapedI
−
7 ,I 2−
8 ,thebranchedI2−
16 ,andtheS-shapedand
linear I4−
16 species to inﬁnite chains [5] .T h es i z ea n d
shape of the polyiodide ions have been found to de-
pend in an unpredictable way on the size and shape of
the counter ion.
In this paper, we review the results of our work on the
iodine interaction with thioamides. Complexes of the so-
called “spoke” and “extended spoke” structures, D ·I2 and
D ·I2 ·I2, respectively, (D is the ligand donor) (ii) iodonium
salts of {[D2−I]+[In]−} (n = 3,7) and {[D2−I]+[FeCl4]−}2 Bioinorganic Chemistry and Applications
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Scheme 1: Ligands used in our work.
formulae and (iii) disulﬁdes of the categories (a) [D−D] and
(b) {[D−DH]+[I3]−} produced by oxidation action of I2,
have been isolated and characterized. A compound of for-
mula {[D2−I]+[I3]−[D ·I2]} containing both types of com-
plexes (i) and (ii) was also isolated.
In addition the results on interaction between di-
iodine with selenium analogs of the antithyroid drug
6-n-propyl-2-thiouracil (PTU) of formulae RSeU have
also been included. Complexes of formulae [(RSeU)I2]
with “spoke” structures have been isolated. These com-
plexes are stable in nonpolar solvents, but they de-
compose in polar solvents, producing diselenide com-
pounds or undertaking deselenation. All these results are
well correlated with the mechanism of action of an-
tithyroid drugs. Finally, we review here our work on
the diiodine interaction with the amides (LO) (L =
organic framework), 2-hydroxy-pyridine and 2-hydroxy-
pyrimidine. Complexes of formulae {(LO)3[(LO)]+ ·I
−
3 },
{(LO)6 ·[(LO)2]2+ ·((1/2)I−) ·((3/2)I
−
7 ) ·(I2)},a sw e l la s
{[LOH]+Cl−I2} have been isolated and characterized.
The ligands used in the present study are summarized in
Scheme 1.
RESULTS AND DISCUSSION
Synthesisofthioamide-diiodinecomplexes
Chargetransfercomplexeswith“spoke”or
“extendedspoke”structures
Reactions between diiodine and the thioamides (1)–(5)
(Scheme 1)leadtotheformationofchargetransfer(ct)com-
plexes with the so-called “spoke” or “extended spoke” struc-
tures (DS ·I2 or DS ·I2 ···I2) according to the general reac-
tion shown in Scheme 2.
Thus, reaction of diiodine with (1), (2), (3), or (4) in
am o l a rr a t i o1:1( I 2 : L) results to the formation of ct
complexes of formulae [(BZT)I2] (17) [1], [(PTU)I2] (18)
[3], [(CBZT)I2] (19) [3], and [(NMBZT)I2] (20) [6]w i t h
spoke structures (Scheme 3). Reactions of diiodine with (1)
or (5) in 2 : 1 (I2 : L) molar ratio form ct complexes of ex-
tended spoke structures with formulae [(BZT)I2I2] (21) [1]
and [(BZIM)I2I2H2O] (22) [1]( Scheme 3).
Table 1 summarizes bond distances and angles of impor-
tance of our ct complexes with spoke and extended spoke
structures.S. K. Hadjikakou and N. Hadjiliadis 3
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Scheme 3: Molecular diagrams of ct complexes with spoke and extended spoke structures.
The I−I bond distances are varying from 2.79 ˚ A, in case
of complexes with weak I−S interaction, to 3.08 ˚ A, as a re-
sult of a strong I−S interaction. The corresponding I−Ib o n d
is subsequently elongated with respect to the corresponding
distance in free I−I in the solid state [19]( 2 .717 ˚ A at 110K
[20]). Bigoli et al [21] has classiﬁed iodine adducts of sul-
fur donors into three classes, depending on I−Ib o n do r -
der (n), calculated from Pauling’s equation d(I−I) = d0 −
0.85 · log(n)( 1)[ w h e r edi sI −I interatomic distance of the
adduct, d0 is the I−I bond distance of gas phase I2 (2.67 ˚ A),
and n is the I−Ib o n do r d e r ][ 18]. When n ≥ 0.6a n d
d(I−I) < 2.85 ˚ A, the adduct is type A, and when n ≤ 0.4
and d(I−I) > 3.01 ˚ A, it is type C. Compounds with inter-
mediate values were classiﬁed as type B. Thus, compounds
(18) and (20) are classiﬁed into A type, compounds (19),
(21), and (22) into B type, whereas compound (17) is C
type.
Figure 1 correlates d(I−I) versus d(I−S). A linear corre-
lation is observed with the exception of complex (17). This
behavior has been already explained [22].
The S−I−I group has a linear structure with an angle of
almost 180◦. The N−C−S−I torsion angle is also found al-
most equal to 180◦ indicating an almost coplanar arrange-
ment of the I2 towards > C=S bond except the case of
[(PTU)I2] complex, where it is found to be −95.93◦.I nf a c t ,
[(PTU)I2]complexistheﬁrstctcomplexwithperpendicular
arrangement of I2 towards > C=S characterized by X-ray
crystallography [3].4 Bioinorganic Chemistry and Applications
Table 1: Selected bond distances and angles of spoke and extended ct complexes.
Complex I−I(I2)(˚ A) I−I(S)(˚ A) I−S(˚ A) I−I−S( ◦)N −C−S−I−(◦) n (e)∗ bond order Type
[(BZT)I2] (17) —3 .077(2) 2.728(6) 174.18(14) 166.40 0.33 C
[(PTU)I2] (18) —2 .826(1) 2.780(1) 175.85(2) −95.93 0.65 A
[(CBZT)I2] (19) —2 .920(1) 2.633(1) 173.78(4) 167.88 0.51 B
[(NMBZT)I2] (20) —2 .7912(1) 2.808(3) 176.94(7) 172.90 0.72 A
[(BZT)I2I2] (21) 2.7504(18) 2.969(2) 2.587(5) 177.78(13) 174.71 0.44 B
[(BZIM)I2I2H2O] (22) 2.767(3) 2.989(2) 2.571(6) 176.76(14) 2.95 0.42 B
∗The I−I bond order calculated from Pauling’s equation d(I−I) = d0 −0.85 ·log(n) (where d is I−I interatomic distance of the adduct, d0
is the I−I bond distance of gas phase I2 (2.67 ˚ A), and n is the I−Ib o n do r d e r )[ 18].
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Figure 1: Correlation between d(I−S) and d(I−I) found for spoke
and extended spoke ct complexes of diiodine, [(BZT)I2] (17),
[(PTU)I2] (18), [(CBZT)I2] (19), [(NMBZT)I2] (20), [(BZT)I2I2]
(21), and [(BZIM)I2I2H2O] (22).
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Scheme 4: 1D intermolecular network of complex [(BZT)I2].
An extended intermolecular 1D network through hydro-
genbondinginteractionisalsoformedincomplex[(BZT)I2]
(17) with N···I = 3.597(18) ˚ A( Scheme 4).
Iodoniumsaltcomplexes
Reaction between diiodine and thioamides such as TZD
(6) or BZIM (5) leads to the formation of iodonium salt
complexes of [{(TZD)2I+}·I
−
3 · 2I2] (23) (Scheme 5)a n d
{[(BZIM)2I+]I
−
3 }{[(BZIM)I2]} (24) (Scheme 5) formulae
according to the reaction in Scheme 2.
The two I−S bond distances are 2.654(6) ˚ A in (23) and
in case of (24) they are 2.597(4) ˚ Aa n d2 .702(4) ˚ A, respec-
tively. The I−I bond distances in I
−
3 counter anions are found
to be equal (I−I = 2.9195(14) ˚ A) in case of (23). In case
of (24) two types of I
−
3 counter anions are observed, one is
symmetric with I(1)−I(2) = 2.9300(12) ˚ A while the other is
not since it participates in hydrogen bonding (I(1A)−I(2A)=
2.880(6) ˚ Aa n dI ( 1 A ) −I(3A) = 3.058(5) ˚ A, resp) and bet-
ter described as I−, interacting with I2(I···I2)[ 11]. The
two hydrogen bonding interactions are taking place between
the I+ and the hydrogen atoms of the amide nitrogen atoms
(H[N]···I = 2.9336(6) ˚ A) in case of (23) (Scheme 5)a n d
I(11)···H−N(11)   of 3.20 ˚ A in case of (24) (Scheme 6). Ab
initio quantum mechanical methods and density functional
theory (DFT) techniques applied on the iodonium part of
(24) suggested that the conformations obtained in the crys-
talline state result from an intermolecular electrostatic inter-
action between the positively charged iodine and the neg-
atively charged NH (total group (NH) charges calculated
−0.005 e for N(11)  , −0.014 e for N(21)  , −0.004 e for
N(13)  ,a n d−0.012 e for N(23)  )[ 6]( Scheme 6).
When (NMBZT) (4) reacts with diiodine in the presence
of FeCl3 i nam o l a rr a t i oo f3:6:1( N M B Z T :I 2 :F e C l 3)
(1), complex {[(NMBZT)2I]+ ·[FeCl4]−} (25) (Scheme 7)
together with {[(NMBZT)2I+]}·[I7]− were formed [6].
The I−S bond distances are I−S = 2.5961(15) ˚ Aa n d
2.6596(14) ˚ A, respectively, with an almost linear S−I+−Sa r -
rangement (S−I−S = 177.77(5)◦)
3NMBZT+6I2 +F eC l 3 −→

1
2

[(NMBZT)2I+[FeCl4]
−]

+

[(NMBZT)2I+]
•[I
−
7 ]

+ unidentiﬁed products.
(1)
Monocationicandneutraldisulﬁdes
The reaction of 2-mercaptopyridine (PYSH) (7) with diio-
dine in a molar ratio of 1 : 2 led to the oxidation and dimer-
ization of the ligand and produced {(PYS−PYSH)+ ·I
−
3 }
(26) (Scheme 8). The structure of the compound consists
of two residues; one cationic (PYS−PYSH)+, containing the
S−S bond linking the two 2-mercapto-pyridine moleculesS. K. Hadjikakou and N. Hadjiliadis 5
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Scheme 10
one of which is protonated, and one I
−
3 counter anion.
In the crystal lattice there are four symmetry-independent
cation-anion pairs. There are only a few crystal struc-
tures reported in the literature containing open chain sta-
ble cations of DS-SD dimers, such as the monocationic:
{[(C4H6N2S−SN2C4H5)2]2+ ·(I
−
3 ) ·(I
−
5 )} [15]. The two I−I
bond distances of the I
−
3 in the four components of com-
plex (26) are 2.887(4) ˚ Aa n d2 .944(3) ˚ A in component a,
2.874(4) ˚ Aa n d2 .957(3) ˚ Ai nb ,2 .968(3) ˚ Aa n d2 .862(3) ˚ Ai n
c, and 2.855(4) ˚ Aa n d2 .927(3) ˚ A in d, respectively, indicat-
ing a slight asymmetry of I
−
3 in this complex (covalent linear
asymmetric).
3D = S
5I2 [D = S
￿I2]+[(D = S)2I]+
￿[I7]
￿
(I)
2I2
(1/2)[(D = S)2I]+
￿[I7]
￿
￿
(IIa)
(IIa)
(a)
3D = S
3I2 [D = S
￿I2].[(D = S)2I]+
￿[I3]
￿
(IIIa)
(3/2)[(D = S)2I]+
￿[I3]
￿
(IIIb)
(IIIb)
(b)
Scheme 11
Moreover, when MNA (8), MBA (9), or PMT (10) reacts
with diiodine under the same experimental conditions as in
the case of the preparation of complex (7), (see above), neu-
tral disulﬁdes were produced with formulae [(MNA)2] (27),
[(MBA)2] (28), and [(PMT)2] (29) according to the reaction
shown in Scheme 2. Scheme 9 shows the disulﬁde formed in
case of (10) with formula [(PMT)2] (29).
Complex (24) isolated from the reaction of (5) and I2 re-
veals the cocrystallization of both a “spoke” structure and
an iodonium salt structure. This leads to the conclusion
that the equilibrium of Scheme 10 is established in solu-
tion.
It has also been shown that the disproportionation
reaction, with the generation of the ionic compound
from thioamide-iodine complexes, exhibits pressure depen-
dence [2]. A pressure increase leads to the ionic iodo-
nium salt (iii) from (ii) (Scheme 10). The favoring of
{[(MBZIM)2I]+[I3]−} (24a) formation is also proved by
computational studies, based on energetic grounds [6].
The conductivity measurements indicate that when diio-
dine is added to a solution of BZIM (5) (D=S), initially both
the neutral (I) and the ionic (IIa) compounds are formed
as it is shown in Scheme 11(a). Further addition of diiodine
results to the ionic complex (IIa). In the case of NMBZT
(Scheme 11(b)) a cocrystallization of both the spoke and
iodonium complexes takes place producing only the iodo-
nium complex, in excess of I2.
For the mechanism of action of antithyroid drugs the re-
action scheme shown in Scheme 12 is followed.
Our results strongly indicate that the antithyroid drugs
PTU (2) and N-Methyl-2-mercapto-imidazoline (MMI)
have a diﬀerent way of action. Thus, (2) together with NM-
BZT (4) forming weak S−Ic tc o m p l e x e s( Table 1) may in-
terfere either by inhibiting TPO activity [26] or by inhibiting
deiodinase (ID-1) enzyme which is responsible for the for-
mation of T3f r o mT4h o r m o n e .S. K. Hadjikakou and N. Hadjiliadis 7
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Scheme 14: Molecular structure of [(n-PrSeU)I2](30).
MMI, TZD (6), PYSH (7), PMT (10), MNA (8), and
MBA (9), on the other hand, that strongly bind to I2 or are
oxidized to disulﬁdes [15] most probably interfere in the for-
mation of monoiodotyrosine (MIT), diiodotyrosine (DIT)
by the tyrosine residues of thyroglobulin Tyr(TG), compet-
ing with active iodine.
Synthesisofselenoamide-diiodinecomplexes
Since thyroid deiodinase contains selenocysteine [27], the
seleno-analog of PTU (PSeU) is expected to exhibit a higher
antithyroid activity than PTU, because of the easier forma-
tion of Enzyme-Se-Se-PSeU species than Enzyme-Se-S-PTU
due to the higher nucleophilicity of Se. To examine this pos-
sibility we have extended our studies to the interaction of I2
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d(I
￿I)
d
(
S
e
￿
I
)
30
41
3841
40
39
Figure 2:Graphicalplotofd(Se−I)versusd(I−I)for[(n-PrSeU)I2]
(30), (tzSeMe) ·I2, (38) (tzSeMe = N-Methyl-thiazolidine-
2(3H)-selone) [23], (btSeMe) ·2I2, (39) (btSeMe = N-Methyl-
benzothiazole-2(3H)-selone) [23], {(L ·I2) ·(L2)+ ·2I
−
3 } (40)
(L = bis(N,N -Dimethyl-imidazolidin-2-yl)-di-selenone) [24],
(mbis) ·2I2, (41) (mbis = 1,1 -bis(3-Methyl-4-imidazolin-2-
selenone)methane) [25].
with selenoamides. Scheme 1 shows the ligand used in this
work. Ligands (11)–(14) were synthesized according the re-
actions shown in Scheme 13.
Reactions of alkyl-selenoamides with diiodine in a 1 : 1
molar ratio in dichloromethane solutions result in the for-
mation of [(RSeU)I2][ R= methyl-, ethyl-, n-propyl-, and
i-propyl-] (Scheme 14).
[(n-PrSeU)I2] (30) was found to be a charge transfer
complex with an Se−I bond. The I−I interatomic distance
of 2.8928(10) ˚ A is longer than that in either the gas phase
(2.677 ˚ A) or crystalline diiodine (2.717 ˚ A at 110K) presum-
ably owing to the Se···I interaction. It is, however, the
shortest such distance measured for a diiodine-selenoamide
complexes suggesting a minimal perturbation resulting from
the Se···I contact, which is the longest measured thus far
[7].TheI−Ibondorderof0.547calculatedfor[(n-PrSeU)I2]
fromPauling’sequationd(I−I) = d0−0.85·log(n)(1)(where8 Bioinorganic Chemistry and Applications
H H
H
HH
H
H
N
N
H
O
H
N
N
H
O
H
H
H
H H
H
Se
Se H H
H
H H
H
H
N
N
H
O
H
N
N
O
H
H H
HH
H
H
Scheme 15: [N-(6-n-Pr-4-pyrimidone)(6-n-Pr-SeU)2](32).
R N
H Se
NH
O
R=Me-(11), Et-(12),
n-Pr-(13), i-Pr-(14)
CH2Cl2
I2 R N
H
+
Se
I
I
￿ NH
O
R=Me-, Et-(33),
n-Pr-(30), i-Pr-
CHCl3
MeOH/MeCN
Me2CO
R N
H
+
Se
I
I
￿
NH
O
R N
H O
NH
O
R=n-Pr-(34)
R N
H Se
N
O
N R
O
HN
R
O
NH
N N
O
R N
H
Se
R=Et- (31), n-Pr-(32)
Scheme 16
disI −Iinteratomicdistanceoftheadduct,d0 istheI−Ibond
distance of gas phase I2 (2.67 ˚ A) and n is the I−Ib o n do r -
der) [18] is the highest such bond order for selenoamide-
diiodine complexes. All these data are consistent with a weak
Se···I interaction, the weakest ever found. According to
Bigoli et al classiﬁcation, complex (30) is classiﬁed in the B
type of adduct. It is interesting to note that the correspond-
ing [(PTU)I2] complex forms a weaker ct complex, with an
I−I bond order of 0.65e [3] compared to the 0.547e found
for [(n-Pr−SeU)I2] which implies a weaker S···I interac-
tion. With the same classiﬁcation the former complex is of A
type, while the latter of B type. Interestingly, there is a lin-
ear correlation between the Se···Ia n dI −I distances (see
Table 1 and Figure 2).
The diselenides [N-(6-Et-4-pyrimidone)(6-Et-SeU)2]
(31) and [N-(6-n-Pr-4-pyrimidone)(6-n-Pr−SeU)2] (32)
(Scheme 15) were produced upon recrystallization of [(n-
PrSeU)I2] (30) and [(n-EtSeU)I2] (33) from acetone,
as oxidation products. On the other hand, deselena-
tion with the formation of 6-n-propyl-2-uracil (n-Pr−U)
(34) was observed when (30) was recrystallized from
methanol/acetonitrile solutions [7].S. K. Hadjikakou and N. Hadjiliadis 9
4
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Figure 3: Polyiodine network established by weak halogen-halogen interactions, in the distance range 3.51 ˚ A–3.58 ˚ A, between I
−
7 and
I2 ···I− ···I2 ions in the {(PYOH)6 ·[(PYOH)2]2+ ·((1/2)I−) ·((3/2)I
−
7 ) ·(I2)}.
In conclusion, while 6-alkyl-2-selenouracil com-
pounds (RSeU) (Scheme 16) are stable in various sol-
vents, including water and other polar or nonpolar
solvents, “spoke” ct complexes of formulae [(RSeU)I2]
are formed in dichloromethane solutions, but are un-
stable in methanol/acetonitrile and/or acetone solutions
(Scheme 16). [(RSeU)I2] is transformed to 6-alkyl-2-uracil
in methanolic/acetonitrile solutions (Scheme 16). Upon
recrystallization of the compound in acetone the diselenides
containing also a covalent C−N bond with an adjacent
PTU molecule are formed possibly through the formation
of a substituted selenouracil as indicated by 1H, 13CN M R
spectra, and ESI-MS spectra. The whole process may be
hydrolytic (Scheme 16).
Synthesisofamide-diiodinecomplexes
The reaction of 2-pyridone (PYOH) (15) with diiodine
in a molar ratio of 2 : 1 and 1 : 2, respectively, re-
sultedtotheformationof{(PYOH)3[(PYOH)]+I
−
3 }(35)and
{(PYOH)6 ·[(PYOH)2]2+ ·((1/2)I−) · ((3/2)I
−
7 ) ·(I2)} (36)
complexes (Scheme 17). The reactions were carried out in
dichloromethane solutions.
The reaction of 2-pyrimidone (PMOH+
2Cl−) (15) with
diiodine in a molar ratio of 1 : 1 resulted to the formation
of {[LOH]+Cl−I2} (37) complex.
Incaseofcomplex(36)thecounteranionsformapolyio-
dine network. Figure 3 shows the polyiodine network es-
tablished by weak halogen-halogen interactions, in the dis-
tance range 3.51 ˚ A–3.58 ˚ A, between I
−
7 and I2 ···I− ···I2
ions forming an inﬁnite chain.
In conclusion, structures containing polyiodide anions
with cationic aromatic ligands as counterparts of formulae
{[(L)(HL+)] · (I−
n)} are known to be synthesized by the
treatment of the appropriate amide with HI [28–30]. In con-
trast, the complexes with PYOH, in the present case, were
formed by the direct reaction of 2-hydroxypyridine with di-
iodine in a molar ratio of 2 : 1 and 1 : 2. This is a re-
dox reaction, where 2-hydroxy-pyridine ﬁrstly is oxidized
to pyridinone-2 radical cation. In the case of 2-hydroxy-
pyridine, however, peroxide structures are not formed like
disulﬁdesinthecaseofPYSH.Polyiodideanionsaresimulta-
neously produced in this case. This should be a consequence
of redox diﬀerences between −SH and OH groups and may
be proven a useful pathway for the synthesis of polyiodide
materials.10 Bioinorganic Chemistry and Applications
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